… -approved repurposed drugs against SARS-CoV-2 into three main categories, antiviral
drugs and non-antiviral drugs, … Figure 2 FDA-approved repurposed drugs against SARS-CoV-2. …

… teams worldwide have focused on the repurposing of Food and … the anti-SARS-CoV-2
activity of these FDA-approved drugs. Thus, in this systematic review, we aim to describe the drug …

… intervention for COVID-19, pharmacological repurposing has … SARS-CoV-2 is an emerging
outbreak and its mode of dissemination is rapid, reaching virtually all countries in the world, …

… this review found some potential in preventing SARS-CoV-2 … international concern,2
there is still a probability of recurring … intervention studies that evaluated the effectiveness of …

… of SARS-CoV-2 has been a tough task for the whole world to deal with. With the absence of
specific drugs or vaccines against SARS-CoV-2, … new drug/vaccine associated interventions. …

… ) has caused a major public health concern across the globe. SARS-CoV-2 is the seventh
… Coronaviruses can spread into the CNS and fingolimod is capable of preventing T-cell …

… mutant SARS-CoV-2. Moreover, we report repurposed drug discovery, which mainly
focuses on virus-based and host-based targets, as well as their inhibitors. SARS-CoV-2 targets …

… a global pandemic precipitated by Severe Acute respiratory syndrome coronavirus 2 (SARS-
CoV-2). … However, in comparison to other CoVs, the SARS-CoV-2 host tropism/ adaptation …

… Since the beginning of the novel coronavirus (SARS-CoV-2) … an exciting approach to the drug
repurposing world [46]. … ATP-competitive inhibitor of RdRp and intervene with the viral RNA …

… drugs for effective intervention in an ongoing pandemic—COVID-19 that has infected over
131 million, with 2.8 million people succumbing to the illness globally … anti-SARS-CoV-2 drugs …